Heart Failure Flashcards

1
Q

Carvedilol MOA

A

Both Beta 1 and Alpha 1 blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Carvedilol Clinical Application

A
  • Chronic HF

- Reduces mortality in moderate and severe HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Carvedilol Toxicity

A
  • Bronchospasm
  • Bradycardia
  • AV block
  • Acute cardiac decompensation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Isosorbide dinitrate MOA

A

Release NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Isosorbide dinitrate effects

A
  • Venodilation

- Reduce preload and ventricular stretch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Isosorbide dinitrate clinical application

A

Acute and chronic heart failure

Angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Isosorbide dinitrate toxicity

A
  1. Postural hypotension
  2. Tachycardia
  3. Headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isosorbide dinitrate interaction

A

Synergistic with phosphodiesterase type 5 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hydralazine MOA

A

Increase NO synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hydralazine effects

A

Reduces afterload and BP

Increases CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hydralazine clinical applications

A
  • Chronic HF in African Americans

- Hydralazine + Nitrates reduces mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hydralazine toxicity

A
  1. Lupus-like syndrome
  2. Tachycadia
  3. Fluid retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nitroprusside MOA

A

-Rapid, powerful vasodilation -reduces preload and afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nitroprusside clinical application

A
  1. Hypertensive emergency

2. Acute cardiac decompensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nitroprusside toxicity

A

Cyanide Toxicity

Thicyanate toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Digoxin MOA

A
  • Inhibits Na+/K+ ATPase pump

- Increased intracellular Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Digoxin effects

A
  • Increases cardiac contractility

- Increases parasympathetic outflow: slowed HR, slowed AV conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Digoxin clinical applications

A
  1. Chronic symptomatic HF

2. Rapid ventricular rate in A-fib

19
Q

Digoxin toxicity

A
  1. GI upset: N/V/D

2. Cardiac arrhythmia

20
Q

Name cardiac glycoside

A

Digoxin

21
Q

Acute heart failure heart failure drugs

A
  1. Bipyridines
  2. Natriuretic peptide
  3. Beta-adrenoceptor agonists
22
Q

Beta-adrenoceptor agonists

A
  1. Dobutamine

2. Dopamine

23
Q

Dobutamine MOA

A

Beta-1 selective agonist

24
Q

Dobutamine effects

A
  1. Increases cardiac contractility

2. Increase CO

25
Q

Dobutamine clinical application

A

Acute decompensated HF

26
Q

How is Dobutamine given?

A

IV only

27
Q

Dopamine MOA

A
  1. Dopamine receptor agonist

2. Higher doses activate Beta and Alpha adrenoreceptors

28
Q

Dopamine effects

A
  1. Increases renal blood flow

2. Higher doses increases cardiac force and BP

29
Q

Dopamine clinical application

A
  1. Acute decompensated HF

2. Shock

30
Q

How is Dopamine given?

A

IV

31
Q

Milrinone MOA

A
  • Phosphodiesterase type 3 inhibitor

- Increased levels of cAMP

32
Q

Milrinone effects

A
  1. Vasodilator
  2. Decrease PVR
  3. Increase cardiac contractility
33
Q

Milrinone clinical application

A

Acute decompensated heart failure

34
Q

Milrinone toxicity

A

Arrhythmias

35
Q

Nesiritide MOA

A

Activates BNP receptors

Increases cGMP

36
Q

Nesiritide effects

A

vasodilation

diuresis

37
Q

Nesiritide clinical application

A

Acute decompensated failure

38
Q

Nesiritide toxicity

A

Renal damage

39
Q

List a natriuretic peptide

A

Nesiritide

40
Q

List a Bipyridine

A

Milrinone

41
Q

Ivabradine MOA

A
  • HCN, if current inhibitor
  • Prolongs diastolic time
  • Reduces HR
42
Q

Ivabradine clinical applications

A
  1. Sx’s of HF that are STABLE
  2. Normal heart beat with a resting HR @ 70 bpm
  3. Taking beta-blocker @ highest dose
43
Q

Overall goal of Ivabradine

A

Reduce risk of hospitalization for worsening HF

44
Q

Ivabradine contraindications

A
  1. BP <90/50
  2. Acute HF
  3. Bradycardia arrhythmias